For: | Borchardt RA, Torres HA. Challenges in managing hepatitis C virus infection in cancer patients. World J Gastroenterol 2014; 20(11): 2771-2776 [PMID: 24659870 DOI: 10.3748/wjg.v20.i11.2771] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i11/2771.htm |
Number | Citing Articles |
1 |
Amy Ly, Heather H Cheng, Laura Alwan. Hepatitis C infection and chemotherapy toxicity. Journal of Oncology Pharmacy Practice 2019; 25(2): 474 doi: 10.1177/1078155217734626
|
2 |
Matthias Pinter, Michael Trauner, Markus Peck-Radosavljevic, Wolfgang Sieghart. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open 2016; 1(2): e000042 doi: 10.1136/esmoopen-2016-000042
|
3 |
Kenneth V. I. Rolston. Infections in Cancer Patients with Solid Tumors: A Review. Infectious Diseases and Therapy 2017; 6(1): 69 doi: 10.1007/s40121-017-0146-1
|
4 |
Andreas Kyvernitakis, Mahnaz Taremi, Boris Blechacz, Jessica Hwang, Ying Jiang, Parag Mahale, Harrys A. Torres. Impact of hepatitis E virus seropositivity on chronic liver disease in cancer patients with hepatitis C virus infection. Hepatology Research 2015; 45(11): 1146 doi: 10.1111/hepr.12460
|
5 |
Romeo-Gabriel Mihăilă. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma. World Journal of Gastroenterology 2016; 22(27): 6214-6223 doi: 10.3748/wjg.v22.i27.6214
|
6 |
Noha Hayek, Mona El Lawindi, Hanan Ali Sayed, Amal Sedrak, Zeinab M. Abd. El Hafeez, Amr Shafik Saad. A Single-Institute Cross-sectional Study of HCV-Positive Cancer Patients’ Quality of Life in Egypt. Open Access Macedonian Journal of Medical Sciences 2022; 10(B): 1016 doi: 10.3889/oamjms.2022.6404
|
7 |
Tatiana Zorina, Alexis Styche. Infection and Cancer: Bi-Directorial Interactions. 2015; : 295 doi: 10.1007/978-3-319-20669-1_14
|
8 |
Barbara Vannata, Emanuele Zucca. Hepatitis C virus-associated B-cell non-Hodgkin lymphomas. Hematology 2014; 2014(1): 590 doi: 10.1182/asheducation-2014.1.590
|
9 |
Mohammad Ali, Shahid Ud Din Wani, Mubashir Hussain Masoodi, Nisar Ahmad Khan, H.G. Shivakumar, Riyaz M. Ali Osmani, Khalid Ahmed Khan. Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review. Clinical Complementary Medicine and Pharmacology 2022; 2(4): 100041 doi: 10.1016/j.ccmp.2022.100041
|
10 |
Isabel Echavarria, J. Rafael Carrión Galindo, Jesús Corral, María Pilar Diz Taín, Fernando Henao Carrasco, Vega Iranzo González-Cruz, Xabier Mielgo-Rubio, Teresa Quintanar, Carlos Rivas Corredor, Pedro Pérez Segura. SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021). Clinical and Translational Oncology 2022; 24(4): 724 doi: 10.1007/s12094-022-02800-3
|
11 |
Harrys A. Torres, George B. McDonald. How I treat hepatitis C virus infection in patients with hematologic malignancies. Blood 2016; 128(11): 1449 doi: 10.1182/blood-2016-05-718643
|
12 |
Mira Atef, Rasha Eletreby, Mohamed Abdallah, Rasha Salama, Wafaa Elakel, Mohamed Hassany, Wael Abdel-Razek, Yehia El Shazly, Wahid Doss, Gamal Esmat. Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00213-z
|
13 |
Kerstin Rauwolf, Heidi Herbrüggen, Stefan Zöllner, Heike Thorer, Olga Makarova, Thomas Kaiser, Aleksandra Pettke, Claudia Rossig, Birgit Burkhardt, Andreas H. Groll. Durable control of hepatitis C through interferon‐free antiviral combination therapy immediately prior to allogeneic haematopoietic stem cell transplantation. Journal of Viral Hepatitis 2019; 26(4): 454 doi: 10.1111/jvh.13046
|
14 |
Murad Kiyas oglu Mamedov, T. N Mamedova, Yu. A. Akhmedov. PERSPECTIVES OF INVESTIGATION OF ONCOLOGICAL ASPECTS OF INFECTION CAUSED WITH HEPATITIS C VIRUS. Russian Journal of Oncology 2019; 24(1-2): 39 doi: 10.18821/1028-9984-2019-24-1-2-39-44
|
15 |
Nidhi Jyotsana, Michael R. King. The Impact of COVID-19 on Cancer Risk and Treatment. Cellular and Molecular Bioengineering 2020; 13(4): 285 doi: 10.1007/s12195-020-00630-3
|
16 |
Vivek R. Bora, Bhoomika M. Patel. The Deadly Duo of COVID-19 and Cancer!. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.643004
|
17 |
|
18 |
Sima Chaudhari, Satyajit Dey Pereira, Meshach Asare-Warehene, Ritam Naha, Shama Prasada Kabekkodu, Benjamin K. Tsang, Kapaettu Satyamoorthy. Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection. Journal of Ovarian Research 2021; 14(1) doi: 10.1186/s13048-021-00787-z
|
19 |
Manjinder Singh Phull, Surender Singh Jadav, Rambabu Gundla, Prathama S. Mainkar. A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors. European Journal of Medicinal Chemistry 2021; 212: 113149 doi: 10.1016/j.ejmech.2020.113149
|
20 |
Andreas Kyvernitakis, Madeleine Duvic, Parag Mahale, Harrys A. Torres. Interferon-Based Treatment for Patients with Mycosis Fungoides and Hepatitis C Virus Infection: A Case Series. American Journal of Clinical Dermatology 2014; 15(5): 451 doi: 10.1007/s40257-014-0084-6
|
21 |
Barbara Vannata, Luca Arcaini, Emanuele Zucca. Hepatitis C virus-associated B-cell non-Hodgkin’s lymphomas: what do we know?. Therapeutic Advances in Hematology 2016; 7(2): 94 doi: 10.1177/2040620715623924
|
22 |
Eric Chow, Zainab Shahid, Elton T. Smith, Michal Kamionek, Saad Z. Usmani. Successful Treatment of Hepatitis C Infection While Receiving Concurrent Chemotherapy for AL Amyloidosis. Clinical Lymphoma Myeloma and Leukemia 2016; 16(4): 237 doi: 10.1016/j.clml.2016.01.003
|
23 |
Saptaparni Ghosh, Minghua L. Chen, Janice Weinberg, Tsion Fikre, Naomi Y. Ko. Hepatitis C Virus Infection and Chemotherapy in Breast Cancer: A Retrospective Chart Analysis. The Oncologist 2020; 25(10): 845 doi: 10.1634/theoncologist.2020-0172
|
24 |
Ana Claudia Marques Barbosa Diaz, Steven Sol Witkin, Cesar de Almeida Neto, Alfredo Mendrone Junior, Vanderson Rocha, Silvia Figueiredo Costa, Jessica Fernandes Ramos, Maria Cassia Mendes-Correa. Prevalence and clinical consequences of Hepatitis C virus infection in patients undergoing hematopoietic stem cell transplantation. Revista do Instituto de Medicina Tropical de São Paulo 2024; 66 doi: 10.1590/s1678-9946202466011
|
25 |
Juan Pablo Alderuccio, Alexandra Stefanovic, Daniel Dammrich, Jennifer R. Chapman, Francisco Vega, Gennaro Selvaggi, Andreas Tzakis, Izidore S. Lossos. Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapy. Leukemia & Lymphoma 2018; 59(9): 2096 doi: 10.1080/10428194.2017.1413187
|